References
- Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension 2011;57:132-40. https://doi.org/10.1161/HYPERTENSIONAHA.110.163576
- Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7. https://doi.org/10.1056/NEJM199007053230105
- Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74. https://doi.org/10.1161/01.CIR.87.5.1468
- Walsh T, Donnelly T, Lyons D. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis? J Am Geriatr Soc 2009;57:140-5. https://doi.org/10.1111/j.1532-5415.2008.02051.x
- Conger JD. Endothelial regulation of vascular tone. Hosp Pract (Off Ed) 1994;29:117-22. 125-6.
- Hermann M, Flammer A, Luscher TF. Nitric oxide in hypertension. J Clin Hypertens (Greenwich) 2006;8:17-29. https://doi.org/10.1111/j.1524-6175.2006.06032.x
- Luscher TF, Noll G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995;118(Suppl.):S81-90. https://doi.org/10.1016/0021-9150(95)90076-4
- Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6. https://doi.org/10.1038/333664a0
- Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6. https://doi.org/10.1038/327524a0
- Stauss HM, Godecke A, Mrowka R, Schrader J, Persson PB. Enhanced blood pressure variability in eNOS knockout mice. Hypertension 1999;33:1359-63. https://doi.org/10.1161/01.HYP.33.6.1359
- Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa SC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 1996;93:13176-81. https://doi.org/10.1073/pnas.93.23.13176
- Bobadilla NA, Gamba G, Tapia E, Garcia-Torres R, Bolio A, Lopez-Zetina P, Herrera-Acosta J. Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol 1998;274:F791-8.
- Jeon BH, Kim CS, Kim HS, Park JB, Nam KY, Chiang SJ. Effect of Korean Red Ginseng on blood pressure and nitric oxide production. Acta Pharmacol Sin 2000;21:1095-100.
- Jeon BH, Kim CS, Park KS, Lee JW, Park JB, Kim KJ, Kim SH, Chang SJ, Nam KY. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol 2000;35:135-41. https://doi.org/10.1016/S0306-3623(01)00096-9
- Huu Tung N, Uto T, Morinaga O, Kim YH, Shoyama Y. Pharmacological effects of ginseng on liver functions and diseases: a minireview. Evid Based Complement Alternat Med 2012;2012:173297.
- Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29:1109-18. https://doi.org/10.1111/j.1745-7254.2008.00869.x
- Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 2011;28:467-95. https://doi.org/10.1039/c0np00057d
- Hien TT, Kim ND, Kim HS, Kang KW. Ginsenoside Rg3 inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules in human endothelial cells. Pharmazie 2010;65:699-701.
- Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells. Mol Med Rep 2012;5:1295-8.
- Hien TT, Kim ND, Pokharel YR, Oh SJ, Lee MY, Kang KW. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicol Appl Pharmacol 2010;246:171-83. https://doi.org/10.1016/j.taap.2010.05.008
- Jung SB, Kim CS, Kim YR, Naqvi A, Yamamori T, Kumar S, Kumar A, Irani I. Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain. PLoS One 2013;8:e65415. https://doi.org/10.1371/journal.pone.0065415
- Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, Liu YH, Li SH, Lian XM, Tang Z. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin Exp Pharmacol Physiol 2008;35:1238-44. https://doi.org/10.1111/j.1440-1681.2008.04997.x
- Jin YR, Yu JY, Lee JJ, You SH, Chung JH, Noh JY, Im JH, Han XH, Kim TJ, Shin KS, et al. Antithrombotic and antiplatelet activities of Korean Red Ginseng extract. Basic Clin Pharmacol Toxicol 2007;100:170-5. https://doi.org/10.1111/j.1742-7843.2006.00033.x
- Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-74.
- Ren HC, Sun JG, Wang GJ, A JY, Xie HT, Zha WB, Yan B, Sun FZ, Hao HP, Gu SH, et al. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats. J Pharm Biomed Anal 2008;48:1476-80. https://doi.org/10.1016/j.jpba.2008.09.045
- Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
- Kim YM, Namkoong S, Yun YG, Hong HD, Lee YC, Ha KS, Lee H, Kwon HJ, Kwon YG, Kim YM. Water extract of Korean Red Ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol Pharm Bull 2007;30:1674-9. https://doi.org/10.1248/bpb.30.1674
- Nakaya Y, Mawatari K, Takahashi A, Harada N, Hata A, Yasui S. The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways. J Med Invest 2007;54:381-4. https://doi.org/10.2152/jmi.54.381
Cited by
- Induction of Thioredoxin Reductase 1 by Korean Red Ginseng Water Extract Regulates Cytoprotective Effects on Human Endothelial Cells vol.2015, pp.None, 2014, https://doi.org/10.1155/2015/972040
- Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subject vol.39, pp.6, 2014, https://doi.org/10.1038/hr.2016.7
- Rg3-enriched Korean Red Ginseng enhances blood pressure stability in spontaneously hypertensive rats vol.5, pp.3, 2016, https://doi.org/10.1016/j.imr.2016.05.006
- Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/6874692
- Monitoring of Organic Acids in Ginseng Roots Produced by Conventional and Environmentally Friendly Farming by Gas Chromatography-Mass Spectrometry vol.39, pp.12, 2014, https://doi.org/10.1002/bkcs.11626
- Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over vol.58, pp.3, 2014, https://doi.org/10.1007/s00394-018-1642-0
- Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models vol.12, pp.3, 2019, https://doi.org/10.3390/ph12030117
- Antihypertensive Effects of Rg3-Enriched Korean Vitamin Ginseng in Spontaneously Hypertensive Rats vol.15, pp.1, 2014, https://doi.org/10.1177/1934578x19900712
- Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities vol.52, pp.1, 2020, https://doi.org/10.1080/03602532.2020.1714645
- Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety vol.11, pp.None, 2014, https://doi.org/10.3389/fphar.2020.00422
- Effects of different polyaniline emeraldine compositions in electrodepositing ginsenoside encapsulated poly(lactic‐co‐glycolic acid) microcapsules coating: Physicochemical characterization vol.108, pp.5, 2020, https://doi.org/10.1002/jbm.a.36891
- Ginseng-Induced Changes to Blood Vessel Dilation and the Metabolome of Rats vol.12, pp.8, 2020, https://doi.org/10.3390/nu12082238
- Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension vol.476, pp.1, 2014, https://doi.org/10.1007/s11010-020-03910-8
- Effects of Ginsenoside Rg3 on Inhibiting Differentiation, Adipogenesis, and ER Stress-Mediated Cell Death in Brown Adipocytes vol.2021, pp.None, 2014, https://doi.org/10.1155/2021/6668665
- Rg3-enriched Korean Red Ginseng extract inhibits blood-brain barrier disruption in an animal model of multiple sclerosis by modulating expression of NADPH oxidase 2 and 4 vol.45, pp.3, 2014, https://doi.org/10.1016/j.jgr.2020.09.001
- Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action vol.169, pp.None, 2021, https://doi.org/10.1016/j.phrs.2021.105647
- The effects of ginseng on the metabolic syndrome: An updated review vol.9, pp.9, 2021, https://doi.org/10.1002/fsn3.2475